A new study suggests that reducing systolic blood pressure below the clinically safe threshold of 120 mmHg over time may produce slight health-protective benefits against…
The Food and Drug Administration approved a new Eli Lilly drug this month that treats Alzheimer’s disease. Kisunla is an IV infusion therapy given once…
Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have unveiled a pioneering study shedding light on the intricate mechanisms underlying Alzheimer’s disease (AD). The…
Distressing dreams in middle-aged and older adults may indicate a higher risk for future cognitive decline and all-cause dementia, according to a study presented at…
Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain…
Racial disparities in dementia are due to social determinants of health, with genetic ancestry playing no role, according to a new study led by researchers…
About 13% of individuals diagnosed with dementia may suffer instead from reversible cognitive decline caused by advanced liver disease, according to researchers from the Virginia…
Scientists investigating Alzheimer’s disease have determined the structure of molecules within a human brain for the very first time.
Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks…
A multi-institutional team of neuroscientists has developed a nasal therapy that cleared the brains of Alzheimer’s mouse models of toxic tau proteins. In their study,…